146 related articles for article (PubMed ID: 37221442)
1. Cardiac safety profile of type II kinase inhibitors: Analysis of post-marketing reports from databases of European Medicine Agency & World Health Organization.
Khurana A; Arora MK; Dubey H
Daru; 2023 Dec; 31(2):107-118. PubMed ID: 37221442
[TBL] [Abstract][Full Text] [Related]
2. Assessment of Neurologic Safety Profile of Immune Checkpoint Inhibitors: Evaluation of Adverse Drug Reaction Reports.
Khurana A; Dubey H; Arora MK
Curr Drug Saf; 2024 Jan; ():. PubMed ID: 38310553
[TBL] [Abstract][Full Text] [Related]
3. Cardiovascular Adverse Drug Reactions of Anti-Calcitonin Gene-Related Peptide Monoclonal Antibodies for Migraine Prevention: An Analysis from the European Spontaneous Adverse Event Reporting System.
Sorbara EE; Barbieri MA; Russo G; Cicala G; Spina E
BioDrugs; 2024 Mar; 38(2):275-285. PubMed ID: 38402495
[TBL] [Abstract][Full Text] [Related]
4. Real World Data on the Utilization Pattern and Safety Profile of Infliximab Originator Versus Biosimilars in Italy: A Multiregional Study.
Scavone C; Sessa M; Clementi E; Corrao G; Leone R; Mugelli A; Rossi F; Spina E; Capuano A
BioDrugs; 2018 Dec; 32(6):607-617. PubMed ID: 30341487
[TBL] [Abstract][Full Text] [Related]
5. Immune Checkpoint Inhibitors and Cardiotoxicity: An Analysis of Spontaneous Reports in Eudravigilance.
Mascolo A; Scavone C; Ferrajolo C; Rafaniello C; Danesi R; Del Re M; Russo A; Coscioni E; Rossi F; Alfano R; Capuano A
Drug Saf; 2021 Sep; 44(9):957-971. PubMed ID: 34145536
[TBL] [Abstract][Full Text] [Related]
6. PCSK9 Inhibitors and Neurocognitive Adverse Drug Reactions: Analysis of Individual Case Safety Reports from the Eudravigilance Database.
di Mauro G; Zinzi A; Scavone C; Mascolo A; Gaio M; Sportiello L; Ferrajolo C; Rafaniello C; Rossi F; Capuano A
Drug Saf; 2021 Mar; 44(3):337-349. PubMed ID: 33351170
[TBL] [Abstract][Full Text] [Related]
7. Do immune checkpoint inhibitors share the same pharmacological feature in the risk of cardiac arrhythmias?
Mascolo A; Sportiello L; Rafaniello C; Donniacuo M; Ruggiero D; Scisciola L; Barbieri M; Rossi F; Paolisso G; Capuano A
Biomed Pharmacother; 2023 Aug; 164():114912. PubMed ID: 37210896
[TBL] [Abstract][Full Text] [Related]
8. Neuropsychiatric Adverse Drug Reactions with Tyrosine Kinase Inhibitors in Gastrointestinal Stromal Tumors: An Analysis from the European Spontaneous Adverse Event Reporting System.
Barbieri MA; Sorbara EE; Russo G; Cicala G; Franchina T; Santarpia M; Silvestris N; Spina E
Cancers (Basel); 2023 Mar; 15(6):. PubMed ID: 36980737
[TBL] [Abstract][Full Text] [Related]
9. Rates of spontaneous reports of adverse drug reactions for drugs reported in children: a cross-sectional study with data from the Swedish adverse drug reaction database and the Swedish Prescribed Drug Register.
Wallerstedt SM; Brunlöf G; Sundström A
Drug Saf; 2011 Aug; 34(8):669-82. PubMed ID: 21751827
[TBL] [Abstract][Full Text] [Related]
10. Safety of Biological Therapies for Severe Asthma: An Analysis of Suspected Adverse Reactions Reported in the WHO Pharmacovigilance Database.
Cutroneo PM; Arzenton E; Furci F; Scapini F; Bulzomì M; Luxi N; Caminati M; Senna G; Moretti U; Trifirò G
BioDrugs; 2024 May; 38(3):425-448. PubMed ID: 38489062
[TBL] [Abstract][Full Text] [Related]
11. Pharmacovigilance in ophthalmology in Switzerland: an analysis of the most frequently reported ocular adverse drug reactions within the last 25 years.
Karrer JE; Giovannoni L; Kullak-Ublick GA; Weiler S
Swiss Med Wkly; 2019 Jun; 149():w20085. PubMed ID: 31256417
[TBL] [Abstract][Full Text] [Related]
12. Maternal, fetal and neonatal outcomes among pregnant women receiving COVID-19 vaccination: The preg-co-vax study.
Mascolo A; di Mauro G; Fraenza F; Gaio M; Zinzi A; Pentella C; Rossi F; Capuano A; Sportiello L
Front Immunol; 2022; 13():965171. PubMed ID: 36263025
[TBL] [Abstract][Full Text] [Related]
13. Immune Checkpoint Inhibitors and Scleroderma: Data from the European Pharmacovigilance Database.
Nicoletti MM; Crisci E; Cosenza V; Riccardi C; Campitiello MR; Ruggiero D; Berrino PM; Docimo G; Scavone C
Drugs Real World Outcomes; 2024 Mar; 11(1):33-41. PubMed ID: 37907712
[TBL] [Abstract][Full Text] [Related]
14. Capillary leak syndrome following COVID-19 vaccination: Data from the European pharmacovigilance database Eudravigilance.
Ruggiero R; Balzano N; Di Napoli R; Mascolo A; Berrino PM; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Immunol; 2022; 13():956825. PubMed ID: 36177033
[TBL] [Abstract][Full Text] [Related]
15. Adverse drug reactions of statins in children and adolescents: a descriptive analysis from VigiBase, the WHO global database of individual case safety reports.
Conte C; Rousseau V; Vert C; Montastruc F; Montastruc JL; Durrieu G; Olivier P
Fundam Clin Pharmacol; 2020 Aug; 34(4):518-520. PubMed ID: 32022302
[TBL] [Abstract][Full Text] [Related]
16. Psychiatric adverse reactions to non-selective RET multi-kinase inhibitors: a large-scale pharmacovigilance analysis.
Wang X; Yin D; Tang Y; Xiao F; Wang S
Front Pharmacol; 2023; 14():1209933. PubMed ID: 37465525
[No Abstract] [Full Text] [Related]
17. Immune Checkpoint Inhibitors and Immune-Related Adverse Drug Reactions: Data From Italian Pharmacovigilance Database.
Ruggiero R; Fraenza F; Scavone C; di Mauro G; Piscitelli R; Mascolo A; Ferrajolo C; Rafaniello C; Sportiello L; Rossi F; Capuano A
Front Pharmacol; 2020; 11():830. PubMed ID: 32581796
[TBL] [Abstract][Full Text] [Related]
18. Comparative Study of Adverse Drug Reactions Associated with Filgrastim and Pegfilgrastim Using the EudraVigilance Database.
Rastogi S; Kalaiselvan V; Bin Jardan YA; Zameer S; Sarwat M
Biology (Basel); 2022 Feb; 11(2):. PubMed ID: 35205206
[TBL] [Abstract][Full Text] [Related]
19. Cardiac Events Potentially Associated to Remdesivir: An Analysis from the European Spontaneous Adverse Event Reporting System.
Rafaniello C; Ferrajolo C; Sullo MG; Gaio M; Zinzi A; Scavone C; Gargano F; Coscioni E; Rossi F; Capuano A
Pharmaceuticals (Basel); 2021 Jun; 14(7):. PubMed ID: 34202350
[TBL] [Abstract][Full Text] [Related]
20. Post-Marketing Surveillance of Statins-A Descriptive Analysis of Psychiatric Adverse Reactions in EudraVigilance.
Pop G; Farcaș A; Butucă A; Morgovan C; Arseniu AM; Pumnea M; Teodoru M; Gligor FG
Pharmaceuticals (Basel); 2022 Dec; 15(12):. PubMed ID: 36558987
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
